The use of alternative medical therapies in patients with systemic lupus erythematosus

Andrew D. Moore, Michelle A. Petri, Susan Manzi, David A. Isenberg, Caroline Gordon, Jean Luc Senécal, Yvan S.T. Pierre, Lawrence Joseph, John Penrod, Paul R. Fortin, Nurhan Sutcliffe, Jean Richard Goulet, Denis Choquette, Tamara Grodzicky, John M. Esdaile, Ann E. Clarke

Research output: Contribution to journalArticle

Abstract

Objective. As part of an ongoing study of health resource utilization and diminished productivity in patients with systemic lupus erythematosus (SLE), the use of alternative medical therapies was assessed. Methods. A cohort of 707 patients with SLE from 3 countries completed questionnaires on demographics, social support, health status (using the Short Form 36 health survey), satisfaction with health care, health resource utilization (conventional resources and alternative therapies), and time losses in labor market and non-labor market activities. Annual direct and indirect costs (1997 Canadian dollars) were calculated and compared for users and nonusers of alternative medical therapies. Results. Among the 707 patients, 352 (49.8%) were found to use alternative therapies and at similar rates across Canada, the United States, and the United Kingdom. Users were younger and better educated than nonusers, exhibited poorer levels of self-rated health status and satisfaction with medical care, and had minimal to no objective evidence of worse disease (according to the revised Systemic Lupus Activity Measure instrument). The mean of log direct medical costs for conventional resources was higher for users of select alternative therapies compared with nonusers. In a logistic regression, neither the number of alternative therapies used nor the individual therapy increased the probability of incurring indirect costs. Conclusion. The use of alternative medical therapies is common in patients with SLE. Users of many alternative medical therapies accrue greater conventional medical costs compared with nonusers. The use of alternative medical therapy may be a marker for care-seeking behavior associated with higher consumption of conventional medical resources in the absence of demonstrable additional morbidity and should be considered in future cost analyses of patients with SLE.

Original languageEnglish (US)
Pages (from-to)1410-1418
Number of pages9
JournalArthritis and rheumatism
Volume43
Issue number6
DOIs
StatePublished - Jun 2000

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'The use of alternative medical therapies in patients with systemic lupus erythematosus'. Together they form a unique fingerprint.

  • Cite this

    Moore, A. D., Petri, M. A., Manzi, S., Isenberg, D. A., Gordon, C., Senécal, J. L., Pierre, Y. S. T., Joseph, L., Penrod, J., Fortin, P. R., Sutcliffe, N., Goulet, J. R., Choquette, D., Grodzicky, T., Esdaile, J. M., & Clarke, A. E. (2000). The use of alternative medical therapies in patients with systemic lupus erythematosus. Arthritis and rheumatism, 43(6), 1410-1418. https://doi.org/10.1002/1529-0131(200006)43:6<1410::AID-ANR27>3.0.CO;2-U